Age and fast initial response predict omalizumab retreatment in chronic urticaria

Michelle A.J. Meertens; Teddy Luijf; Esmee A.M. van Lindonk; Reineke Soegiharto; Salma Assil; Mehran Alizadeh Aghdam; Petra A. Kentie; Andre C. Knulst; Martijn B.A. van Doorn; Heike Röckmann

doi:10.1016/j.jaip.2023.07.030

Age and fast initial response predict omalizumab retreatment in chronic urticaria

Michelle A.J. Meertens, Teddy Luijf, Esmee A.M. van Lindonk, Reineke Soegiharto, Salma Assil, Mehran Alizadeh Aghdam, Petra A. Kentie, Andre C. Knulst, Martijn B.A. van Doorn, Heike Röckmann^*

^*Corresponding author for this work

Dermatology

Research output: Contribution to journal › Article › Academic › peer-review

8 Citations (Scopus)

52 Downloads (Pure)

Original language	English
Pages (from-to)	3556-3558.e1
Journal	Journal of Allergy and Clinical Immunology: In Practice
Volume	11
Issue number	11
Early online date	28 Jul 2023
DOIs	https://doi.org/10.1016/j.jaip.2023.07.030
Publication status	Published - Nov 2023

Bibliographical note

© 2023 The Authors. Published by Elsevier Inc. on behalf of the American Academy
of Allergy, Asthma & Immunology.

Access to Document

10.1016/j.jaip.2023.07.030Licence: CC BY

1-s2.0-S2213219823008036-mainProof, 370 KBLicence: CC BY

Cite this

Meertens, M. A. J., Luijf, T., van Lindonk, E. A. M., Soegiharto, R., Assil, S., Alizadeh Aghdam, M., Kentie, P. A., Knulst, A. C., van Doorn, M. B. A., & Röckmann, H. (2023). Age and fast initial response predict omalizumab retreatment in chronic urticaria. Journal of Allergy and Clinical Immunology: In Practice, 11(11), 3556-3558.e1. https://doi.org/10.1016/j.jaip.2023.07.030

@article{8a0c2b990d934223b803f8cb6d4914f2,

title = "Age and fast initial response predict omalizumab retreatment in chronic urticaria",

author = "Meertens, \{Michelle A.J.\} and Teddy Luijf and \{van Lindonk\}, \{Esmee A.M.\} and Reineke Soegiharto and Salma Assil and \{Alizadeh Aghdam\}, Mehran and Kentie, \{Petra A.\} and Knulst, \{Andre C.\} and \{van Doorn\}, \{Martijn B.A.\} and Heike R{\"o}ckmann",

note = "{\textcopyright} 2023 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma \& Immunology.",

year = "2023",

month = nov,

doi = "10.1016/j.jaip.2023.07.030",

language = "English",

volume = "11",

pages = "3556--3558.e1",

journal = "Journal of Allergy and Clinical Immunology: In Practice",

issn = "2213-2198",

publisher = "American Academy of Allergy, Asthma and Immunology",

number = "11",

}

TY - JOUR

T1 - Age and fast initial response predict omalizumab retreatment in chronic urticaria

AU - Meertens, Michelle A.J.

AU - Luijf, Teddy

AU - van Lindonk, Esmee A.M.

AU - Soegiharto, Reineke

AU - Assil, Salma

AU - Alizadeh Aghdam, Mehran

AU - Kentie, Petra A.

AU - Knulst, Andre C.

AU - van Doorn, Martijn B.A.

AU - Röckmann, Heike

PY - 2023/11

Y1 - 2023/11

UR - https://www.scopus.com/pages/publications/85168534270

U2 - 10.1016/j.jaip.2023.07.030

DO - 10.1016/j.jaip.2023.07.030

M3 - Article

C2 - 37517795

AN - SCOPUS:85168534270

SN - 2213-2198

VL - 11

SP - 3556-3558.e1

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 11

ER -

Age and fast initial response predict omalizumab retreatment in chronic urticaria

Bibliographical note

Access to Document

Other files and links

Cite this